Skip to main content

View full-text article in PMC

. 2022 Apr 14;25(2):351–358. doi: 10.1038/s41391-022-00534-5

Table 2.

SUVmax metrics and SUV ratios in malignant and benign lesions (n = 157).

Variable	Group		P value
Variable	Malignant (n = 114)	Benign (n = 43)	P value
SUVmax early	10.9 ± 12.5	2.7 ± 3.7	0.000^a
SUVmax delay	14.6 ± 16.7	2.9 ± 4.0	0.000^a
△SUVmax	3.7 ± 5.1	0.2 ± 1.2	0.000^a
RI(%)	34.0 ± 39.3	9.9 ± 64.3	0.005^a
SUV ratio early	22.5 ± 26.3	5.4 ± 5.3	0.000^a
SUV ratio delay	33.4 ± 36.1	7.2 ± 9.7	0.000^a
Ratio(SUV ratio delay/early)	1.6 ± 0.7	0.9 ± 0.5	0.000^a

Values presented as mean ± SD or number.

^astands for significant difference between the two groups (p < 0.05).